Arndt Vogel: Excellent review, many open questions, Targeting cancers with KRAS-G12D mutations.
Arndt Vogel has recently shared 0n Twitter:
”Next batter up! Targeting cancers with KRAS-G12D mutations at Trends in Cancer.
Excellent review, many open questions:
- Impact of tissue of origin & co-mutational landscape on tumor biology.
- Biomarkers of response.
- What drives resistance?
- Which combinations?”
For the article click here
Source: Arndt Vogel/Twitter
Arndt Vogel, MD, is a managing senior consultant and professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. He is the Head of the GI-Cancer Center and of the Center for Personalized Medicine at Medical School Hannover. Prof Vogel is a member of societies including ESMO, ASCO, and EASL, and he chairs the Hepatobiliary Cancer Study Group of the AIO, a collaborative group in clinical oncology in Germany. His scientific focus is translational and clinical research in gastrointestinal cancer.